AwardTape · Defense awards · Medical · Drugs and biologicals · HT942525F0103
HT942525F0103: $9.7K BPA call to Harvard Bioscience Inc
Harvard Bioscience Inc holds a BPA call from Defense Health Agency with $9.7K obligated since Oct 2023, against a ceiling of $9.7K. Latest action Jun 4, 2025.
Surgery training services
| PIID | HT942525F0103 |
|---|---|
| Type | BPA call |
| Parent award | W81XWH22A0001 |
| Company | Harvard Bioscience Inc |
| Agency | Defense Health Agency |
| Contracting office | ARMY MED RES ACQ ACTIVITY |
| Category | Medical · Drugs and biologicals |
| PSC | 6509 DRUGS AND BIOLOGICALS, VETERINARY USE |
| NAICS | 339113 SURGICAL APPLIANCE AND SUPPLIES MANUFACTURING |
| Obligated since Oct 2023 | $9.7K |
| Total obligated (lifetime) | $9.7K |
| Ceiling (base and all options) | $9.7K |
| Base date | Jun 4, 2025 |
| Latest action | Jun 4, 2025 |
| End date | Jul 31, 2025 |
| Actions since Oct 2023 | 1 |
| Pricing | Firm fixed price |
| Competition | Not competed under simplified acquisition |
| Place of performance | TX |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial